NASDAQ:MOTS - Motus GI Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.22 -0.17 (-5.01 %)
(As of 12/10/2018 04:00 PM ET)
Previous Close$3.39
Today's Range$3.12 - $3.44
52-Week Range$3.03 - $10.66
Volume16,500 shs
Average Volume68,387 shs
Market Capitalization$53.19 million
P/E Ratio-2.46
Dividend YieldN/A
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Current SymbolNASDAQ:MOTS
Previous Symbol


Debt-to-Equity RatioN/A
Current Ratio5.24
Quick Ratio5.22


Trailing P/E Ratio-2.46
Forward P/E Ratio-2.98
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales5,052.18
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)($1.28)
Net Income$-13,200,000.00
Net MarginsN/A
Return on Equity-151.96%
Return on Assets-114.68%


Outstanding Shares15,690,000
Market Cap$53.19 million
OptionableNot Optionable

Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) posted its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.33) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.27) by $0.06. View Motus GI's Earnings History.

When is Motus GI's next earnings date?

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Motus GI.

What price target have analysts set for MOTS?

5 brokerages have issued 1-year target prices for Motus GI's shares. Their forecasts range from $8.00 to $14.50. On average, they expect Motus GI's stock price to reach $10.50 in the next twelve months. This suggests a possible upside of 226.1% from the stock's current price. View Analyst Price Targets for Motus GI.

What is the consensus analysts' recommendation for Motus GI?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Has Motus GI been receiving favorable news coverage?

News headlines about MOTS stock have trended very positive on Monday, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Motus GI earned a media sentiment score of 3.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of Motus GI's key competitors?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 56)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 47)
  • Mr. Timothy P. Moran, CEO & Director
  • Ms. Hagit Ephrath, VP Health Economics, Regulatory & Clinical Affairs
  • Gil Balog, Gen. Mang. of Israel

When did Motus GI IPO?

(MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Who are Motus GI's major shareholders?

Motus GI's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Lombard Odier Asset Management USA Corp (0.80%), Eaton Vance Management (0.26%), Renaissance Technologies LLC (0.17%) and Private Advisor Group LLC (0.13%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Institutional Ownership Trends for Motus GI.

Which major investors are buying Motus GI stock?

MOTS stock was bought by a variety of institutional investors in the last quarter, including Lombard Odier Asset Management USA Corp, Eaton Vance Management, Renaissance Technologies LLC and Private Advisor Group LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Insider Buying and Selling for Motus GI.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $3.22.

How big of a company is Motus GI?

Motus GI has a market capitalization of $53.19 million and generates $10,000.00 in revenue each year. The company earns $-13,200,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis. Motus GI employs 39 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 786-459-1831 or via email at [email protected]

MarketBeat Community Rating for Motus GI (NASDAQ MOTS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel